Marpai (MRAI) Stock Price, News & Analysis

Company Overview

Marpai Inc. is a technology-driven healthcare benefits management company that leverages data analytics and artificial intelligence to optimize health outcomes and control costs for self-insured employers. Its flagship Marpai Health Platform integrates personalized care pathways, advanced member engagement tools and real-time claims analytics. By combining machine learning models with clinical expertise, Marpai identifies risk patterns early and guides members toward cost-effective, high-quality care.

Marpai’s suite of services encompasses underwriting, care coordination, pharmacy benefits management and virtual health coaching, all delivered through a unified digital interface. The platform offers proactive notifications, personalized recommendations and continuous support to help members navigate complex healthcare decisions. Employers using Marpai’s solutions gain greater visibility into cost drivers and can realize measurable reductions in total medical expenses.

Founded by a team of healthcare and technology professionals, Marpai is headquartered in the United States and primarily serves mid-sized to large self-insured organizations across diverse industries. The company’s data-driven approach underpins sustainable cost management and enhances member satisfaction through transparent pricing, targeted interventions and evidence-based care pathways.

Marpai began trading on the NASDAQ under the symbol MRAI, marking its transition to a public company committed to advancing innovation in digital health. While focused on the U.S. market, Marpai continues to explore strategic partnerships and product enhancements designed to expand its capabilities and refine its precision health insights.

Key Stats

• Today's Range: $1.09 to $1.19
• 50-Day Range: $1.02 to $1.49
• 52-Week Range: $0.43 to $1.68
• Volume: 9,055 shs
• Average Volume: 16,792 shs
• Market Capitalization: $20.96 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MRAI Stock Analysis - Frequently Asked Questions

How have MRAI shares performed this year?

Marpai's stock was trading at $0.95 at the beginning of the year. Since then, MRAI stock has increased by 20.5% and is now trading at $1.1450.

How were Marpai's earnings last quarter?

Marpai, Inc. (NASDAQ:MRAI) posted its earnings results on Thursday, May, 9th. The company reported ($0.46) EPS for the quarter. The firm earned $7.39 million during the quarter.

When did Marpai's stock split?

Marpai's stock reverse split before market open on Thursday, June 29th 2023.The 1-4 reverse split was announced on Thursday, June 29th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 29th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

When did Marpai IPO?

Marpai (MRAI) raised $25 million in an initial public offering (IPO) on Wednesday, October 27th 2021. The company issued 6,300,000 shares at $4.00 per share. ThinkEquity served as the underwriter for the IPO.

How do I buy shares of Marpai?

Shares of MRAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Marpai own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Marpai investors own include NVIDIA (NVDA), Meta Platforms (META), Snowflake (SNOW), iShares Core S&P 500 ETF (IVV), Tesla (TSLA), Airbnb (ABNB) and Allegion (ALLE).

Company Calendar

• Last Earnings: 5/09/2024
• Today: 9/25/2025
• Next Earnings (Estimated): 11/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Miscellaneous health & allied services, not elsewhere classified
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:MRAI
• CIK: 1844392
• Web: www.marpaihealth.com
• Phone: 646-303-3483
• Fax: N/A
• Employees: 150
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.87)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$28.75 million
• Net Margins: -85.70%
• Pretax Margin: -86.66%
• Return on Equity: N/A
• Return on Assets: -100.23%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.82
• Quick Ratio: 0.82

Sales & Book Value

• Annual Sales: $34.87 million
• Price / Sales: 0.60
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.72) per share
• Price / Book: -0.67

Miscellaneous

• Outstanding Shares: 18,309,000
• Free Float: 5,605,000
• Market Cap: $20.96 million
• Optionable: No Data
• Beta: 4.66